Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Dermatology Diagnostic and Therapeutic Devices
Revenue, means the sales value of Dermatology Diagnostic and Therapeutic Devices
This report studies sales (consumption) of Dermatology Diagnostic and Therapeutic Devices in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Agfa-Gevaert N.V.
Astellas Pharma, Inc.
Cutera, Inc.
Dino-Lite Europe/IDCP B.V.
Galderma S.A.
Genentech, a Roche Company
GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
LEO Pharma A/S
Michelson Diagnostics Ltd.
Novartis International AG
Valeant Pharmaceuticals International, Inc.
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Dermatology Diagnostic and Therapeutic Devices in each application, can be divided into
Application 1
Application 2
Application 3
United States Dermatology Diagnostic and Therapeutic Devices Market Report 2017
1 Dermatology Diagnostic and Therapeutic Devices Overview
1.1 Product Overview and Scope of Dermatology Diagnostic and Therapeutic Devices
1.2 Classification of Dermatology Diagnostic and Therapeutic Devices
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Dermatology Diagnostic and Therapeutic Devices
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Dermatology Diagnostic and Therapeutic Devices (2011-2021)
1.4.1 United States Dermatology Diagnostic and Therapeutic Devices Sales and Growth Rate (2011-2021)
1.4.2 United States Dermatology Diagnostic and Therapeutic Devices Revenue and Growth Rate (2011-2021)
2 United States Dermatology Diagnostic and Therapeutic Devices Competition by Manufacturers
2.1 United States Dermatology Diagnostic and Therapeutic Devices Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Dermatology Diagnostic and Therapeutic Devices Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Dermatology Diagnostic and Therapeutic Devices Average Price by Manufactures (2015 and 2016)
2.4 Dermatology Diagnostic and Therapeutic Devices Market Competitive Situation and Trends
2.4.1 Dermatology Diagnostic and Therapeutic Devices Market Concentration Rate
2.4.2 Dermatology Diagnostic and Therapeutic Devices Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Dermatology Diagnostic and Therapeutic Devices Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Dermatology Diagnostic and Therapeutic Devices Sales and Market Share by States (2011-2016)
3.2 United States Dermatology Diagnostic and Therapeutic Devices Revenue and Market Share by States (2011-2016)
3.3 United States Dermatology Diagnostic and Therapeutic Devices Price by States (2011-2016)
4 United States Dermatology Diagnostic and Therapeutic Devices Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Dermatology Diagnostic and Therapeutic Devices Sales and Market Share by Type (2011-2016)
4.2 United States Dermatology Diagnostic and Therapeutic Devices Revenue and Market Share by Type (2011-2016)
4.3 United States Dermatology Diagnostic and Therapeutic Devices Price by Type (2011-2016)
4.4 United States Dermatology Diagnostic and Therapeutic Devices Sales Growth Rate by Type (2011-2016)
5 United States Dermatology Diagnostic and Therapeutic Devices Sales (Volume) by Application (2011-2016)
5.1 United States Dermatology Diagnostic and Therapeutic Devices Sales and Market Share by Application (2011-2016)
5.2 United States Dermatology Diagnostic and Therapeutic Devices Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities
6 United States Dermatology Diagnostic and Therapeutic Devices Manufacturers Profiles/Analysis
6.1 Agfa-Gevaert N.V.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.1.2.1 Type I
6.1.2.2 Type II
6.1.3 Agfa-Gevaert N.V. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Astellas Pharma, Inc.
6.2.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.2.2.1 Type I
6.2.2.2 Type II
6.2.3 Astellas Pharma, Inc. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Cutera, Inc.
6.3.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.3.2.1 Type I
6.3.2.2 Type II
6.3.3 Cutera, Inc. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Dino-Lite Europe/IDCP B.V.
6.4.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.4.2.1 Type I
6.4.2.2 Type II
6.4.3 Dino-Lite Europe/IDCP B.V. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 Galderma S.A.
6.5.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.5.2.1 Type I
6.5.2.2 Type II
6.5.3 Galderma S.A. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
6.6 Genentech, a Roche Company
6.6.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.6.2.1 Type I
6.6.2.2 Type II
6.6.3 Genentech, a Roche Company Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
6.7.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.7.2.1 Type I
6.7.2.2 Type II
6.7.3 GlaxoSmithKline plc (Stiefel Laboratories, Inc.) Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.7.4 Main Business/Business Overview
6.8 LEO Pharma A/S
6.8.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.8.2.1 Type I
6.8.2.2 Type II
6.8.3 LEO Pharma A/S Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.8.4 Main Business/Business Overview
6.9 Michelson Diagnostics Ltd.
6.9.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.9.2.1 Type I
6.9.2.2 Type II
6.9.3 Michelson Diagnostics Ltd. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.9.4 Main Business/Business Overview
6.10 Novartis International AG
6.10.2 Dermatology Diagnostic and Therapeutic Devices Product Type, Application and Specification
6.10.2.1 Type I
6.10.2.2 Type II
6.10.3 Novartis International AG Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
6.10.4 Main Business/Business Overview
6.11 Valeant Pharmaceuticals International, Inc.
7 Dermatology Diagnostic and Therapeutic Devices Manufacturing Cost Analysis
7.1 Dermatology Diagnostic and Therapeutic Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dermatology Diagnostic and Therapeutic Devices
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Dermatology Diagnostic and Therapeutic Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dermatology Diagnostic and Therapeutic Devices Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Dermatology Diagnostic and Therapeutic Devices Market Forecast (2016-2021)
11.1 United States Dermatology Diagnostic and Therapeutic Devices Sales, Revenue Forecast (2016-2021)
11.2 United States Dermatology Diagnostic and Therapeutic Devices Sales Forecast by Type (2016-2021)
11.3 United States Dermatology Diagnostic and Therapeutic Devices Sales Forecast by Application (2016-2021)
11.4 Dermatology Diagnostic and Therapeutic Devices Price Forecast (2016-2021)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Dermatology Diagnostic and Therapeutic Devices
Table Classification of Dermatology Diagnostic and Therapeutic Devices
Figure United States Sales Market Share of Dermatology Diagnostic and Therapeutic Devices by Type in 2015
Figure Type I Picture
Figure Type II Picture
Figure Type III Picture
Table Application of Dermatology Diagnostic and Therapeutic Devices
Figure United States Sales Market Share of Dermatology Diagnostic and Therapeutic Devices by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure United States Dermatology Diagnostic and Therapeutic Devices Sales and Growth Rate (2011-2021)
Figure United States Dermatology Diagnostic and Therapeutic Devices Revenue and Growth Rate (2011-2021)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales of Key Manufacturers (2015 and 2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Dermatology Diagnostic and Therapeutic Devices Sales Share by Manufacturers
Figure 2016 Dermatology Diagnostic and Therapeutic Devices Sales Share by Manufacturers
Table United States Dermatology Diagnostic and Therapeutic Devices Revenue by Manufacturers (2015 and 2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Dermatology Diagnostic and Therapeutic Devices Revenue Share by Manufacturers
Table 2016 United States Dermatology Diagnostic and Therapeutic Devices Revenue Share by Manufacturers
Table United States Market Dermatology Diagnostic and Therapeutic Devices Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Dermatology Diagnostic and Therapeutic Devices Average Price of Key Manufacturers in 2015
Figure Dermatology Diagnostic and Therapeutic Devices Market Share of Top 3 Manufacturers
Figure Dermatology Diagnostic and Therapeutic Devices Market Share of Top 5 Manufacturers
Table United States Dermatology Diagnostic and Therapeutic Devices Sales by States (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales Share by States (2011-2016)
Figure United States Dermatology Diagnostic and Therapeutic Devices Sales Market Share by States in 2015
Table United States Dermatology Diagnostic and Therapeutic Devices Revenue and Market Share by States (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Revenue Share by States (2011-2016)
Figure Revenue Market Share of Dermatology Diagnostic and Therapeutic Devices by States (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Price by States (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales by Type (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales Share by Type (2011-2016)
Figure United States Dermatology Diagnostic and Therapeutic Devices Sales Market Share by Type in 2015
Table United States Dermatology Diagnostic and Therapeutic Devices Revenue and Market Share by Type (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Dermatology Diagnostic and Therapeutic Devices by Type (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Price by Type (2011-2016)
Figure United States Dermatology Diagnostic and Therapeutic Devices Sales Growth Rate by Type (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales by Application (2011-2016)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales Market Share by Application (2011-2016)
Figure United States Dermatology Diagnostic and Therapeutic Devices Sales Market Share by Application in 2015
Table United States Dermatology Diagnostic and Therapeutic Devices Sales Growth Rate by Application (2011-2016)
Figure United States Dermatology Diagnostic and Therapeutic Devices Sales Growth Rate by Application (2011-2016)
Table Agfa-Gevaert N.V. Basic Information List
Table Agfa-Gevaert N.V. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Agfa-Gevaert N.V. Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Astellas Pharma, Inc. Basic Information List
Table Astellas Pharma, Inc. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma, Inc. Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Cutera, Inc. Basic Information List
Table Cutera, Inc. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cutera, Inc. Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Dino-Lite Europe/IDCP B.V. Basic Information List
Table Dino-Lite Europe/IDCP B.V. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dino-Lite Europe/IDCP B.V. Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Galderma S.A. Basic Information List
Table Galderma S.A. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galderma S.A. Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Genentech, a Roche Company Basic Information List
Table Genentech, a Roche Company Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech, a Roche Company Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table GlaxoSmithKline plc (Stiefel Laboratories, Inc.) Basic Information List
Table GlaxoSmithKline plc (Stiefel Laboratories, Inc.) Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc (Stiefel Laboratories, Inc.) Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table LEO Pharma A/S Basic Information List
Table LEO Pharma A/S Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table LEO Pharma A/S Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Michelson Diagnostics Ltd. Basic Information List
Table Michelson Diagnostics Ltd. Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Michelson Diagnostics Ltd. Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Novartis International AG Basic Information List
Table Novartis International AG Dermatology Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis International AG Dermatology Diagnostic and Therapeutic Devices Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals International, Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology Diagnostic and Therapeutic Devices
Figure Manufacturing Process Analysis of Dermatology Diagnostic and Therapeutic Devices
Figure Dermatology Diagnostic and Therapeutic Devices Industrial Chain Analysis
Table Raw Materials Sources of Dermatology Diagnostic and Therapeutic Devices Major Manufacturers in 2015
Table Major Buyers of Dermatology Diagnostic and Therapeutic Devices
Table Distributors/Traders List
Figure United States Dermatology Diagnostic and Therapeutic Devices Production and Growth Rate Forecast (2016-2021)
Figure United States Dermatology Diagnostic and Therapeutic Devices Revenue and Growth Rate Forecast (2016-2021)
Table United States Dermatology Diagnostic and Therapeutic Devices Production Forecast by Type (2016-2021)
Table United States Dermatology Diagnostic and Therapeutic Devices Consumption Forecast by Application (2016-2021)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales Forecast by States (2016-2021)
Table United States Dermatology Diagnostic and Therapeutic Devices Sales Share Forecast by States (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...